5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Haleos Labs Ltd.

•
haleoslabs.comBSE: 540679NSE: HALEOSLABS
Market Cap₹ 442 Cr.
Current Price
High / Low₹ 1,774 / 1,091
Stock P/E27.9
Book Value₹ 720
Price to Book1.66
Dividend Yield0.10 %
ROCE14.0 %
ROE11.4 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Operating margins have improved to 12.0% from 8.7%
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 0.99x)
  • Company generates healthy free cash flow
  • Company has a consistent dividend-paying track record
  • Company maintains a comfortable, low leverage position

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Company has a low return on equity of 9.2% over last 3 years
  • Company has a low return on capital employed of 11.7%
  • Company has delivered a poor sales growth of 5.3% over past five years
  • Growth is decelerating - 3Y profit CAGR (-5.6%) trails the 5Y trend (18.5%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.HALEOSLABS1462.5027.98442.160.101.84-58.0172.94-11.6012.6012.50
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
75687186877883857978816368
69586276736770806867695763
Operating Profit59911141213611111265
OPM %6.87%13.96%12.66%12.52%15.91%15.03%15.77%6.56%13.70%13.87%14.32%9.78%7.11%
1012010210010
Interest2223222222112
Depreciation3333233333333
Profit before Tax15581099377735
Tax %48.53%34.80%34.71%25.03%32.29%29.79%27.64%19.82%31.02%29.36%27.77%29.56%38.63%
Net Profit1336666355523
2.3210.3110.9619.6321.3719.8720.608.8517.0616.4617.887.3910.71

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
0216213344257260346315300333290
0187200312233230314289265289256
Operating Profit-028133224303126354433
OPM %—13.20%6.21%9.43%9.26%11.45%9.09%8.40%11.51%13.29%11.52%
023321145442
Interest06455555986
Depreciation06667788101011
Profit before Tax-01862413193318193023
Tax %-0.00%29.89%-1.64%29.99%31.42%31.96%23.03%28.06%31.64%28.86%31.00%
Net Profit-0137179132513132116
EPS0.0042.8121.5055.0230.2643.5683.9543.7243.2270.69—
Dividend Payout %0.00%0.00%0.00%2.73%0.00%3.44%1.79%3.43%3.47%2.12%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
5%
3 Years:
-1%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
18%
3 Years:
-6%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
—

RETURN ON EQUITY

10 Years:
12%
5 Years:
11%
3 Years:
9%
Last Year:
11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Sep 23

₹ 0.15

Rs.1.5000 per share(15%)Final Dividend

2025

Sep 24

₹ 0.15

Rs.1.5000 per share(15%)Dividend

2024

Sep 23

₹ 0.15

Rs.1.5000 per share(15%)Dividend

2023

Sep 22

₹ 0.15

Rs.1.5000 per share(15%)Dividend

2022

Sep 22

₹ 0.15

Rs.1.5000 per share(15%)Dividend

2021

Sep 20

₹ 0.15

Rs.1.5000 per share(15%)Dividend

2026

Sep 8

₹ 0.15

Rs.1.5000 per share(15%)Final Dividend

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital0033333333
-08285102110123148161173194
0262746505062867770
Trade Payables0554484456271555046
0181822243836364855
Total Liabilities0181178257232276319341352367
07368879410199140138150
Capital Work in Progress00712321160
00526262623232323
0444974615981807561
000000004965
Cash & Bank0012292111
0644766467993965967
Total Assets0181178257232276319341352367

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
0259341726-781528
Cash from Investing0-8-7-43-13-6-7-28-14-14
Cash from Financing0-12-118-2-81523-1-14
0-002-18-8-100

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025

Shareholding Pattern

Numbers in percentages

Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
71.4171.4171.4171.4171.4171.8072.1172.11
0.020.000.000.030.000.000.000.00
0.000.000.000.000.030.290.300.31
Government0.000.000.000.000.000.000.000.00
28.5728.5928.5928.5628.5727.9127.6027.58

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-09
Updates

2026-09-09 - HALEOS LABS LIMITED has informed the Exchange regarding 'Annual Report (Weblink)'.

2026-09-08
Copy of Newspaper Publication

2026-09-08 - HALEOS LABS LIMITED has informed the Exchange about Copy of Newspaper Publication for AGM notice

2026-09-08
Shareholders meeting

2026-09-08 - HALEOS LABS LIMITED has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026

2026-09-05
General Updates

2026-09-05 - HALEOS LABS LIMITED has informed the Exchange about Events Calendar (AGM)

2026-09-05
Record Date

2026-09-05 - HALEOS LABS LIMITED has informed the Exchange that Record date for the purpose of Dividend is 23-Sep-2026.

2026-09-01
Shareholders meeting

2026-09-01 - HALEOS LABS LIMITED has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

2026-08-24
Updates

2026-08-24 - HALEOS LABS LIMITED has informed the Exchange regarding 'Communication To Shareholders (TDS Related)'.

2026-08-07
Copy of Newspaper Publication

2026-08-07 - HALEOS LABS LIMITED has informed the Exchange about Copy of Newspaper Publication

2026-08-05
Updates

2026-08-05 - HALEOS LABS LIMITED has informed the Exchange regarding 'Update (Material Subsidiary)'.

News

Recent coverage and analyst commentary for HALEOSLABS

Loading news…

🤖

AI Stock Analyst

Haleos Labs Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login